Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Depreciation & Amortization (CF) (2021 - 2025)

Historic Depreciation & Amortization (CF) for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to $7006.0.

  • HeartSciences' Depreciation & Amortization (CF) fell 4264.43% to $7006.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $27637.0, marking a year-over-year decrease of 2529.93%. This contributed to the annual value of $37599.0 for FY2025, which is 3480.21% up from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Depreciation & Amortization (CF) is $7006.0, which was down 4264.43% from $7111.0 recorded in Q3 2025.
  • HeartSciences' 5-year Depreciation & Amortization (CF) high stood at $12215.0 for Q4 2024, and its period low was $3717.0 during Q1 2024.
  • Its 5-year average for Depreciation & Amortization (CF) is $7393.8, with a median of $6919.0 in 2021.
  • Over the last 5 years, HeartSciences' Depreciation & Amortization (CF) had its largest YoY gain of 6167.89% in 2024, and its largest YoY loss of 4585.58% in 2024.
  • HeartSciences' Depreciation & Amortization (CF) (Quarter) stood at $6601.0 in 2021, then increased by 3.21% to $6813.0 in 2022, then rose by 12.08% to $7636.0 in 2023, then soared by 59.97% to $12215.0 in 2024, then tumbled by 42.64% to $7006.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $7006.0 for Q4 2025, versus $7111.0 for Q3 2025 and $7513.0 for Q2 2025.